Rinvoq ER 45 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DR26F6C8F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,874
Award facts
- Contract value 100% obligated
- $34,874.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $34,874.29 delivery order to Amerisourcebergen Drug Corp on July 9, 2026, for RINVOQ ER 45 mg tablets.
The order represents a firm fixed-price call against Amerisourcebergen's single-award indefinite delivery contract with DLA Troop Support Medical (SPE2DX series), which supports the Pharmaceutical Prime Vendor Global Program Generation V for military healthcare supply. Place of performance is Conshohocken, PA. The order is scheduled for ultimate completion by July 10, 2026.
Quick answers
Who was awarded contract SPE2DR26F6C8F?
SPE2DR26F6C8F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 9, 2026.
How much is contract SPE2DR26F6C8F worth?
The government has obligated $34,874 on SPE2DR26F6C8F.
Is contract SPE2DR26F6C8F an order under another contract?
Yes. SPE2DR26F6C8F is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F6C8F competed?
The extent of competition for SPE2DR26F6C8F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award